# Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome

> **NCT02656056** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 22 (actual)

## Conditions studied

- Obesity

## Interventions

- **OTHER:** Food: (Q-Can Plus fermented soybean beverage)

## Key facts

- **NCT ID:** NCT02656056
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02656056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02656056, "Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02656056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*